Pharmaceutical Technology on MSN
FDA approves meningioma label warning on Pfizer’s contraceptive injection
Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused their meningiomas.
Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback